Abstract
It is well recognized that there is important cross-communication and inter-regulation that occurs between the endocrine, immune, and nervous systems during development and adult life. This chapter will specifically focus on interactions between the immune and endocrine systems related to (1) autoimmune diseases of the endocrine glands due to disruption of tolerance and development of adaptive immunity, (2) the effects of drugs and chemicals on induction of endocrine autoimmune diseases, (3) the newly recognized role of innate immunity in endocrine disorders, such as diabetes mellitus and obesity, (4) the effects of cytokines from immune cells on endocrine cells, and (5) effects of select hormones, such as glucocorticoids, prolactin, and parathyroid hormone on the immune system.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aaltonen J, Bjorses P, Perheentupa J, Horelli-Kuitunen N, Palotie A, Peltonen L, Lee YS, Francis F, HenningSteffen TC, Leharach H, Yaspo M-L (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17(4):399–403
Adachi N, Yamaguchi K, Miyake Y, Honda S, Nagasaki K, Akiyama Y, Adachi I, Abe K (1990) Parathyroid hormone-related protein is a possible autocrine growth inhibitor for lymphocytes. Biochem Biophys Res Commun 166(3):1088–1094
Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322(26):1829–1836. doi:10.1056/NEJM199006283222601
Åkerblom HK, Knip M (1998) Putative environmental factors in type 1 diabetes. Diabetes Metab Rev 14(1):31–68. doi:10.1002/(SICI)1099-0895(199803)14:1<31::AID-DMR201>3.0.CO;2-A
American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–S90. doi:10.2337/dc14-S081
Andersen CJ, Murphy KE, Fernandez ML (2016) Impact of obesity and metabolic syndrome on immunity. Adv Nutr 7(1):66–75. doi:10.3945/an.115.010207
Anderson MS (2008) Update in endocrine autoimmunity. J Clin Endocrinol Metab 93(10):3663–3670. doi:10.1210/jc.2008-1251
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298(5597):1395–1401. doi:10.1126/science.1075958
Antony GK, Dudek AZ (2010) Interleukin 2 in cancer therapy. Curr Med Chem 17(29):3297–3302
Archambeaud-Mouveroux F, Huc MC, Nadalon S, Fournier MP, Canivet B (1989) Autoimmune insulin syndrome. Biomed Pharmacother 43(8):581–586
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383(9911):69–82. doi:10.1016/s0140-6736(13)60591-7
Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG (2006) Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 116(6):1713–1722. doi:10.1172/JCI25112
Bacchetta R, Strollo R, Napoli N (2011) IPEX Syndrome: Clinical Profile, Biological Features, and Current Treatment. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 129–142
Bach JF (2005) Infections and autoimmune diseases. J Autoimmun 25(Suppl):74–80. doi:10.1016/j.jaut.2005.09.024
Bahn RS (2010) Graves' ophthalmopathy. N Engl J Med 362(8):726–738. doi:10.1056/NEJMra0905750
Baker PR, Baschal EE, Fain PR, Triolo TM, Nanduri P, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA, Barker JM, Eisenbarth GS (2010) Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endocrinol Metab 95(10):E263–E270. doi:10.1210/jc.2010-0508
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y (2003a) Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 4(8):586–593. doi:10.1038/sj.gene.6364018
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y (2003b) Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 100(25):15119–15124. doi:10.1073/pnas.2434175100
Barker JM (2011) Autoimmune polyendocrine syndrome type 2: pathophysiology, natural history, and clinical manifestations. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 143–154
Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E (1998) Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol 138(6):603–614
Bednarek J, Furmaniak J, Wedlock N, Kiso Y, Baumann-Antczak A, Fowler S, Krishnan H, Craft JA, Smith BR (1992) Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett 309(1):51–55. doi:10.1016/0014-5793(92)80737-2
Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi A, De Bellis A (2003) Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149(5):363–376. doi:10.1530/eje.0.1490363
Bellucci PN, Gonzalez Bagnes MF, Di Girolamo G, Gonzalez CD (2016) Potential effects of nonsteroidal anti-inflammatory drugs in the prevention and treatment of type 2 diabetes mellitus. J Pharm Pract. doi:10.1177/0897190016649551
Bensing S, Hulting AL, Höög A, Ericson K, Kämpe O (2007) Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. J Endocrinol Invest 30(2):153–162. doi:10.1007/bf03347415
Betterle C, Greggio NA, Volpato M (1998) Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metabol 83(4):1049–1055. doi:10.1210/jcem.83.4.4682
Betterle C, Zanchetta R (2003) Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 74(1):9–33
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Juppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26(10):2317–2337. doi:10.1002/jbmr.483
Bjerneroth G, Juhlin C, Gudmundsson S, Rastad J, Åkerström G, Klareskog L (1998) Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. Surgery 124(3):503–509. doi:10.1016/S0039-6060(98)70096-0
Blizzard RM, Chee D, Davis W (1966) The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol 1(2):119–128
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE (2004) Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89(7):3474–3476. doi:10.1210/jc.2003-031854
Bodansky HJ, Dean BM, Bottazzo GF, Grant PJ, McNally J, Hambling MH, Wales JK (1986) Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet 328(8520):1351–1353. doi:10.1016/S0140-6736(86)92003-9
Boelen A, Kwakkel J, Wieland CW, St Germain DL, Fliers E, Hernandez A (2009) Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae. Endocrinology 150(4):1984–1990. doi:10.1210/en.2008-1133
Bornstein SR, Rutkowski H, Vrezas I (2004) Cytokines and steroidogenesis. Mol Cell Endocrinol 215(1-2):135–141. doi:10.1016/j.mce.2003.11.022
Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313(6):353–360. doi:10.1056/NEJM198508083130604
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36(4):337–338, http://www.nature.com/ng/journal/v36/n4/suppinfo/ng1323_S1.html
Braley-Mullen H, Sharp GC, Medling B, Tang H (1999) Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 12(3):157–165. doi:10.1006/jaut.1999.0272
Braley-Mullen H, Yu S (2000) Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2 h4 mice. J Immunol 165(12):7262–7269
Bratland E, Hellesen A, Husebye ES (2013) Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3. Mol Cell Endocrinol 365(1):75–83. doi:10.1016/j.mce.2012.09.004
Bratland E, Husebye ES (2011) Cellular immunity and immunopathology in autoimmune Addison's disease. Mol Cell Endocrinol 336(1-2):180–190. doi:10.1016/j.mce.2010.12.015
Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES (2009) T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J Clin Endocrinol Metab 94(12):5117–5124. doi:10.1210/jc.2009-1115
Brodie GM, Wallberg M, Santamaria P, Wong FS, Green EA (2008) B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes 57(4):909–917. doi:10.2337/db07-1256
Brown EM (2009) Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin North Am 38(2):437–445. doi:10.1016/j.ecl.2009.01.001
Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko S-A, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27(1):68–73, http://www.nature.com/ng/journal/v27/n1/suppinfo/ng0101_68_S1.html
Burek CL, Talor MV (2009) Environmental triggers of autoimmune thyroiditis. J Autoimmun 33(3-4):183–189. doi:10.1016/j.jaut.2009.09.001
Bussone G, Mouthon L (2009) Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev 8(4):332–336. doi:10.1016/j.autrev.2008.11.004
Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, Corneli RB, Ferretti E, Gulino A, Grasso F, De Simone C, Di Mario U, Falorni A, Boirivant M, Dotta F (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48(8):1565–1575. doi:10.1007/s00125-005-1831-2
Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR (2008) Pituitary autoimmunity: 30 years later. Autoimmun Rev 7(8):631–637. doi:10.1016/j.autrev.2008.04.016
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26(5):599–614. doi:10.1210/er.2004-0011
Christen U, von Herrath MG (2004) Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 40(14–15):1113–1120. doi:10.1016/j.molimm.2003.11.014
Cnop M, Welsh N, Jonas J-C, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(suppl 2):S97–S107. doi:10.2337/diabetes.54.suppl_2.S97
Colobran R, Armengol Mdel P, Faner R, Gartner M, Tykocinski LO, Lucas A, Ruiz M, Juan M, Kyewski B, Pujol-Borrell R (2011) Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet 20(17):3415–3423. doi:10.1093/hmg/ddr247
Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209(1):51–60. doi:10.1084/jem.20111187
Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2–13. doi:10.1016/j.mce.2010.04.005
Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10(19):2025–2037. doi:10.1093/hmg/10.19.2025
Cuddihy RM, Dutton CM, Bahn RS (1995) A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5(2):89–95. doi:10.1089/thy.1995.5.89
Dalberg UN, Haase C, Hornum L, Markholst H (2011) The BB rat. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 183–197
Darling G, Goldstein DS, Stull R, Gorschboth CM, Norton JA (1989) Tumor necrosis factor: immune endocrine interaction. Surgery 106(6):1155–1160
De Bellis A, Bizzaro A, Bellastella A (2011a) Pituitary autoimmunity. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 547–568
De Bellis A, Bizzaro N, Bellastella A (2011b) Pituitary autoimmunity. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 547–567
de Vries EM, Fliers E, Boelen A (2015) The molecular basis of the non-thyroidal illness syndrome. J Endocrinol 225(3):R67–R81. doi:10.1530/JOE-15-0133
Devendra D, Eisenbarth GS (2004) Interferon alpha—a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 111(3):225–233. doi:10.1016/j.clim.2004.01.008
Diamanti A, Capriati T, Bizzarri C, Panetta F, Ferretti F, Ancinelli M, Romano F, Locatelli M (2013) Celiac disease and endocrine autoimmune disorders in children: an update. Expert Rev Clin Immunol 9(12):1289–1301. doi:10.1586/1744666X.2013.850029
Díaz L, Muñoz MD, González L, Lira-Albarrán S, Larrea F, Méndez I (2013) Prolactin in the immune system. In: Toth BE, Nagy GM (eds) Prolactin. Intech, Wiltshire, pp 53–82. doi:10.5772/53538
Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11(2):98–107. doi:10.1038/nri2925
Dorshkind K, Horseman ND (2000) The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 21(3):292–312. doi:10.1210/edrv.21.3.0397
du Pre MF, Sollid LM (2015) T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol 29(3):413–423. doi:10.1016/j.bpg.2015.04.001
Eisenbarth GS (1986) Type I diabetes mellitus. N Engl J Med 314(21):1360–1368. doi:10.1056/NEJM198605223142106
Eisenbarth GS (2011) Immunoendocrinology: scientific and clinical aspects. Contemporary endocrinology. Humana, New York, NY
Everds NE, Snyder PW, Bailey KL, Bolon B, Creasy DM, Foley GL, Rosol TJ, Sellers T (2013) Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol 41(4):560–614. doi:10.1177/0192623312466452
Falorni A (2011) Addison’s disease. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 399–413
Falorni A, Brozzetti A, Torre DL, Tortoioli C, Gambelunghe G (2008) Association of genetic polymorphisms and autoimmune Addison’s disease. Expert Rev Clin Immunol 4(4):441–456. doi:10.1586/1744666X.4.4.441
Flynn JC, Meroueh C, Snower DP, David CS, Kong YM (2007) Depletion of CD4(+)CD25(+) regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 147(3):547–554. doi:10.1111/j.1365-2249.2006.03303.x
Foulis A, Farquharson M, Meager A (1987) Immunoreactive α-interferon in Insulin-secreting β cells in type 1 diabetes mellitus. Lancet 330(8573):1423–1427. doi:10.1016/S0140-6736(87)91128-7
Freeman M, Weetman AP (1992) T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin Exp Immunol 88(2):275–279
Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB (1999) Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison’s disease. J Clin Endocrinol Metabol 84(10):3701–3707. doi:10.1210/jcem.84.10.6069
Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF, Weetman AP (2007) The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92(6):2107–2114. doi:10.1210/jc.2006-2466
Geara AS, Castellanos MR, Bassil C, Schuller-Levis G, Park E, Smith M, Goldman M, Elsayegh S (2010) Effects of parathyroid hormone on immune function. Clin Dev Immunol 74(2):83–90. doi:10.1155/2010/418695
Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A (2006) MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J Clin Endocrinol Metab 91(10):4107–4111. doi:10.1210/jc.2006-0855
Gillis D, Volpe R, Daneman D (1998) A young boy with a thyroid Yo-Yo. J Pediatr Endocrinol Metab 11:467–470. doi:10.1515/JPEM.1998.11.3.467
Goldman J, Baldwin D, Rubenstein AH, Klink DD, Blackard WG, Fisher LK, Roe TF, Schnure JJ (1979) Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Investig 63(5):1050–1059
Goswami R, Brown E, Kochupillai N, Gupta N, Rani R, Kifor O, Chattopadhyay N (2004) Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 150(1):9–18. doi:10.1530/eje.0.1500009
Greenen V, Chrousos G (2004) Immunoendocrinology in health and disease. Marcel Decker, New York, NY
Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9(5):367–377. doi:10.1038/nrm2391
Gutenberg A, Buslei R, Fahlbusch R, Buchfelder M, Brück W (2005) Immunopathology of primary hypophysitis: implications for pathogenesis. Am J Surg Pathol 29(3):329–338
Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F (1995) Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181(5):1847–1855
Hanafusa T, Chiovato L, Doniach D, Pujol-Borrell R, Russell RCG, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity. Lancet 322(8359):1111–1115. doi:10.1016/S0140-6736(83)90628-1
Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 32(2):126–134. doi:10.1007/bf00505185
Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, Liau LM (2015) HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis. J Clin Endocrinol Metab 100(11):4092–4097. doi:10.1210/jc.2015-2702
Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E (2014) The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. Clin Exp Immunol 176(3):351–362. doi:10.1111/cei.12291
Hill NJ, Hultcrantz M, Sarvetnick N, Flodström-Tullberg M (2007) The target tissue in autoimmunity – an influential niche. Eur J Immunol 37(3):589–597. doi:10.1002/eji.200636368
Hober D, Sauter P (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6(5):279–289
Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, Villanueva R, Tomer Y (2006) Possible interaction between HLA-DRβ1 and thyroglobulin variants in Graves' disease. Thyroid 16(4):351–355. doi:10.1089/thy.2006.16.351
Horvath E, Kovacs K (2002) Folliculo-stellate cells of the human pituitary: a type of adult stem cell? Ultrastruct Pathol 26(4):219–228. doi:10.1080/01913120290104476
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271(5249):665–670
Hu C, Ding H, Li Y, Pearson JA, Zhang X, Flavell RA, Wong FS, Wen L (2015) NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci U S A 112(36):11318–11323. doi:10.1073/pnas.1513509112
Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2(5-6):231–237. doi:10.1242/dmm.001180
Husebye ES, Kämpe O (2011) Autoimmune polyendocrine syndrome type I: man. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 115–128
Husebye E, Lovas K (2009) Pathogenesis of primary adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 23(2):147–157. doi:10.1016/j.beem.2008.09.004
Hutchings PR, Verma S, Phillips JM, Harach SZ, Howlett S, Cooke A (1999) Both CD4+ T cells and CD8+ T cells are required for iodine accelerated thyroiditis in NOD mice. Cell Immunol 192(2):113–121. doi:10.1006/cimm.1998.1446
Ismail AA (2016) The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med. doi:10.1515/cclm-2015-1255
Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P (2014) Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med 6(230):230–245. doi:10.1126/scitranslmed.3008002
Iwamoto M, Sakihama T, Kimura N, Tasaka K, Onaya T (1991) Augmented interleukin 6 production by rat thyrocytes (FRTL5): effect of interleukin 1 beta and thyroid-stimulating hormone. Cytokine 3(4):345–349
Jacobson EM, Tomer Y (2007a) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28(2-3):85–98. doi:10.1016/j.jaut.2007.02.006
Jacobson EM, Tomer Y (2007b) The genetic basis of thyroid autoimmunity. Thyroid 17(10):949–961. doi:10.1089/thy.2007.0153
Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, Wee JH, Choi SP (2013) Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 75(4):342–347. doi:10.1016/j.diagmicrobio.2012.12.011
Ji ZF, Zhang DY, Weng SQ, Shen XZ, Liu HY, Dong L (2012) POEMS syndrome: a report of 14 cases and review of the literature. ISRN Gastroenterol 2012:584287. doi:10.5402/2012/584287
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356(12):1216–1225. doi:10.1056/NEJMoa061592
Joshi MN, Whitelaw BC, Palomar MTP, Wu Y, Carroll PV (2016) Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol. doi:10.1111/cen.13063
Kagnoff MF, Paterson YJ, Kumar PJ, Kasarda DD, Carbone FR, Unsworth DJ, Austin RK (1987) Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 28(8):995–1001
Kalliomäki M, Satokari R, Lähteenoja H, Vähämiko S, Grönlund J, Routi T, Salminen S (2012) Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 54(6):727–732. doi:10.1097/MPG.0b013e318241cfa8
Kanczkowski W, Zacharowski K, Wirth MP, Ehrhart-Bornstein M, Bornstein SR (2009) Differential expression and action of Toll-like receptors in human adrenocortical cells. Mol Cell Endocrinol 300(1-2):57–65. doi:10.1016/j.mce.2008.10.028
Kanda H, Tateya S, Tamori Y, Kotani K, K-i H, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Investig 116(6):1494–1505. doi:10.1172/JCI26498
Kasagi K, Iwata M, Misaki T, Konishi J (2003) Effect of iodine restriction on thyroid function in patients with primary hypothyroidism. Thyroid 13(6):561–567. doi:10.1089/105072503322238827
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Investig 95(5):2111–2119
Khan FA, Al-Jameil N, Khan MF, Al-Rashid M, Tabassum H (2015) Thyroid dysfunction: an autoimmune aspect. Int J Clin Exp Med 8(5):6677–6681
Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4 + CD25+ T regulatory cells. Nat Immunol 4(4):337–342. doi:10.1038/ni909
Kifor O, McElduff A, LeBoff MS, Moore FD Jr, Butters R, Gao P, Cantor TL, Kifor I, Brown EM (2004) Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 89(2):548–556. doi:10.1210/jc.2003-031054
Kifor O, Moore FD Jr, Delaney M, Garber J, Hendy GN, Butters R, Gao P, Cantor TL, Kifor I, Brown EM, Wysolmerski J (2003) A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88(1):60–72. doi:10.1210/jc.2002-020249
Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae S-C, Tokuhiro S, Chang X, Sekine A, Takahashi A, Tsunoda T, Ohnishi Y, Kaufman KM, Kang CP, Kang C, Otsubo S, Yumura W, Mimori A, Koike T, Nakamura Y, Sasazuki T, Yamamoto K (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37(5):478–485, http://www.nature.com/ng/journal/v37/n5/suppinfo/ng1540_S1.html
Kolypetri P, Noel NA, Carayanniotis KA, Carayanniotis G (2010) Iodine content of thyroglobulin in NOD.H2h4 mice developing iodine-accelerated autoimmune thyroiditis. Hormones 9(2):151–160
Kontogeorgos G, Messini I, Kyrodimou E, Giannikaki L, Zois E, Koukoulis G, Tsagarakis S (2002) Immunohistochemical localization of interleukin-6 in peripheral human endocrine glands. Endocrine 17(2):135–140. doi:10.1385/ENDO:17:2:135
Kroemer G, Francese C, Martinez C (1992) The role of interleukin 2 in the development of autoimmune thyroiditis. Int Rev Immunol 9(2):107–123. doi:10.3109/08830189209061786
Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxford Med Case Rep 2015(3):237–240. doi:10.1093/omcr/omv023
Kumar V, Valeski JE, Wortsman J (1996) Celiac disease and hypoparathyroidism: cross-reaction of endomysial antibodies with parathyroid tissue. Clin Diagn Lab Immunol 3(2):143–146
Kwon G, Xu G, Marshall CA, McDaniel ML (1999) Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. J Biol Chem 274(26):18702–18708
Lamb MM, Miller M, Seifert JA, Frederiksen B, Kroehl M, Rewers M, Norris JM (2015) The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes 16(1):31–38. doi:10.1111/pedi.12115
Lamb MM, Morris JM (2011) Epidemiology of type 1 diabetes. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 267–278
Lavin Y, Merad M (2013) Macrophages: gatekeepers of tissue integrity. Cancer Immunol Res 1(4):201–209
Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y (2015) Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun 64:82–90. doi:10.1016/j.jaut.2015.07.009
Levy BM, Hampton S, Dreizen S, Hampton JK Jr (1972) Thyroiditis in the marmoset (Callithrix spp. and Saguinus spp.). J Comp Pathol 82(1):99–103
Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N (1996) Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Investig 97(4):910–914
Lissoni P, Rovelli F, Rivolta MR, Frigerio C, Mandala M, Barni S, Ardizzoia A, Malugani F, Tancini G (1997) Acute endocrine effects of interleukin-12 in cancer patients. J Biol Regul Homeost Agents 11(4):154–156
Lopez E, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel K, Badenhoop K (2004) A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 151(2):193–197. doi:10.1530/eje.0.1510193
Lowenberg M, Verhaar AP, van den Brink GR, Hommes DW (2007) Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 13(4):158–163. doi:10.1016/j.molmed.2007.02.001
Lupi I, Broman KW, Tzou SC, Gutenberg A, Martino E, Caturegli P (2008) Novel autoantigens in autoimmune hypophysitis. Clin Endocrinol (Oxf) 69(2):269–278. doi:10.1111/j.1365-2265.2008.03180.x
Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P (2009) Autoimmune forms of hypoglycemia. Medicine 88(3)
Magitta NF, Boe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE, Joner G, Njolstad PR, Kvien TK, Forre O, Knappskog PM, Husebye ES (2009) A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 10(2):120–124. doi:10.1038/gene.2008.85
Magnuson AM, Thurber GM, Kohler RH, Weissleder R, Mathis D, Benoist C (2015) Population dynamics of islet-infiltrating cells in autoimmune diabetes. Proc Natl Acad Sci U S A 112(5):1511–1516. doi:10.1073/pnas.1423769112
Mahzari M, Liu D, Arnaout A, Lochnan H (2015) Immune checkpoint inhibitor therapy associated hypophysitis. Clin Med Insights Endocrinol Diabetes 8:21–28. doi:10.4137/CMED.S22469
Makita N, Sato J, Manaka K, Shoji Y, Oishi A, Hashimoto M, Fujita T, Iiri T (2007) An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci U S A 104(13):5443–5448. doi:10.1073/pnas.0701290104
Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43(4):661–672. doi:10.1002/hep.21146
Marasco G, Di Biase AR, Schiumerini R, Eusebi LH, Iughetti L, Ravaioli F, Scaioli E, Colecchia A, Festi D (2016) Gut microbiota and celiac disease. Dig Dis Sci 61(6):1461–1472. doi:10.1007/s10620-015-4020-2
Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF (1997) Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves’ disease. J Clin Endocrinol Metab 82(10):3361–3366. doi: 10.1210/jcem.82.10.4299
McCauley LK, Rosol TJ, Merryman JI, Capen CC (1992) Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology 130(1):300–306. doi:10.1210/endo.130.1.1309334
McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG (2015) T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523(7562):612–616. doi:10.1038/nature14468
McLachlan SM, Nagayama Y, Rapoport B (2005) Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26(6):800–832. doi:10.1210/er.2004-0023
Mereiles L, Li M, Loo D, Liu E (2011) Celiac disease and intestinal endocrine autoimmunity. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 535–545
Merkler D, Horvath E, Bruck W, Zinkernagel RM, del la Torre JC, Pinschewer DD (2006) “Viral déjà vu” elicits organ-specific immune disease independent of reactivity to self. J Clin Investig 116(5):1254–1263. doi:10.1172/JCI27372
Michels A, Jeffrey J, Eisenbarth GS (2011) Genetics of type 1 diabetes. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 251–265
Michels AW, Eisenbarth GS (2010) Immunologic endocrine disorders. J Allergy Clin Immunol 125(2 Suppl 2):S226–S237. doi:10.1016/j.jaci.2009.09.053
Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, Berdelou A, Varga A, Bahleda R, Hollebecque A, Massard C, Fuerea A, Ribrag V, Gazzah A, Armand JP, Amellal N, Angevin E, Noel N, Boutros C, Mateus C, Robert C, Soria JC, Marabelle A, Lambotte O (2016) Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54:139–148. doi:10.1016/j.ejca.2015.11.016
Mirocha S, Elagin RB, Salamat S, Jaume JC (2009) T regulatory cells distinguish two types of primary hypophysitis. Clin Exp Immunol 155(3):403–411. doi:10.1111/j.1365-2249.2008.03828.x
Mitchell AL, Cordell HJ, Soemedi R, Owen K, Skinningsrud B, Wolff AB, Ericksen M, Undlien D, Husebye E, Pearce SH (2009) Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. J Clin Endocrinol Metab 94(12):5139–5145. doi:10.1210/jc.2009-1404
Mitchell AL, Pearce SH (2012) Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol 8(5):306–316. doi:10.1038/nrendo.2011.245
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metabol 82(12):4196–4200. doi:10.1210/jcem.82.12.4450
Mooij P, de Wit HJ, Drexhage HA (1993) An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopathol 69(2):189–198. doi:10.1006/clin.1993.1169
Morshed SA, Latif R, Davies TF (2009) Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150(1):519–529. doi:10.1210/en.2008-0878
Morshed SA, Latif R, Davies TF (2011a) Immunopathogenesis of Graves’ disease. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 457–482
Morshed SA, Latif R, Davies TF (2011b) Immunopathogenesis of Graves’ disease. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 457–481
Muixi L, Carrascal M, Alvarez I, Daura X, Marti M, Armengol MP, Pinilla C, Abian J, Pujol-Borrell R, Jaraquemada D (2008) Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J Immunol 181(1):795–807. doi:10.4049/jimmunol.181.1.795
Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø BG, Fougner KJ, Trovik T, Sørheim JI, Husebye ES (2002) Autoimmune adrenocortical failure in norway autoantibodies and human leukocyte antigen class II associations related to clinical features. J Clin Endocrinol Metabol 87(2):618–623. doi:10.1210/jcem.87.2.8192
Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56(Pt 12):1669–1674. doi:10.1099/jmm.0.47410-0
Nagayama Y, Abiru N (2011) Animal models of autoimmune thyroid disease. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 415–426
Nagayama Y, McLachlan SM, Rapoport B, Oishi K (2004) Graves’ hyperthyroidism and the hygiene hypothesis in a mouse model. Endocrinology 145(11):5075–5079. doi:10.1210/en.2004-0683
Nakamura K, Kawasaki E, Imagawa A, Awata T, Ikegami H, Uchigata Y, Kobayashi T, Shimada A, Nakanishi K, Makino H, Maruyama T, Hanafusa T, Research Committee on Type 1 Diabetes of the Japan Diabetes S (2011) Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care 34(9):2084–2089. doi:10.2337/dc10-2274
Narayana SK, Woods DR, Boos CJ (2011) Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab 2(3):115–126. doi:10.1177/2042018811398516
Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, Lane JA, Lavant E, Rappner R, Louey A, Concannon P, Mychaleckyj JC, Erlich HA, for the Type 1 Diabetes Genetics C (2010) HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 diabetes genetics consortium. Diabetes 59(11):2972–2979. doi:10.2337/db10-0699
Norris JM, Yin X, Lamb MM et al (2007) Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298(12):1420–1428. doi:10.1001/jama.298.12.1420
O’Dwyer DT, Smith AI, Matthew ML, Andronicos NM, Ranson M, Robinson PJ, Crock PA (2002) Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as α-enolase. J Clin Endocrinol Metabol 87(2):752–757. doi:10.1210/jcem.87.2.8205
Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, Palau F, Nova E, Marcos A, Polanco I, Ribes-Koninckx C, Ortigosa L, Izquierdo L, Sanz Y (2015) The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 64(3):406–417. doi:10.1136/gutjnl-2014-306931
Oram RA, Jones AG, Besser RE, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57(1):187–191. doi:10.1007/s00125-013-3067-x
Ostuni R, Kratochvill F, Murray PJ, Natoli G (2015) Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol 36(4):229–239. doi:10.1016/j.it.2015.02.004
Pakala SV, Chivetta M, Kelly CB, Katz JD (1999) In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J Exp Med 189(7):1053–1062
Pallais JC, Kifor O, Chen Y-B, Slovik D, Brown EM (2004) Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 351(4):362–369. doi:10.1056/NEJMoa040008
Palma GD, Capilla A, Nova E, Castillejo G, Varea V, Pozo T, Garrote JA, Polanco I, Lopez A, Ribes-Koninckx C, Marcos A, Garcia-Novo MD, Calvo C, Ortigosa L, Pena-Quintana L, Palau F, Sanz Y (2012) Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One 7(2), e30791. doi:10.1371/journal.pone.0030791
Pani M, Seissler J, Usadel K, Badenhoop K (2002) Vitamin D receptor genotype is associated with Addison's disease. Eur J Endocrinol 147(5):635–640. doi:10.1530/eje.0.1470635
Paolo WF Jr, Nosanchuk JD (2006) Adrenal infections. Int J Infect Dis 10(5):343–353. doi:10.1016/j.ijid.2005.08.001
Papanicolaou DA, Vgontzas AN (2000) Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab 85(3):1331–1333. doi:10.1210/jcem.85.3.6582
Pelletier-Morel L, Fabien N, Mouhoub Y, Boitard C, Larger E (2008) Hyperparathyroidism in a patient with autoimmune polyglandular syndrome. Intern Med 47(21):1911–1915. doi:10.2169/internalmedicine.47.1355
Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361(22):2143–2152. doi:10.1056/NEJMoa0904452
Peterson ME (2014) Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter. J Endocrinol 223(2):T97–T114. doi:10.1530/JOE-14-0461
Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27(3):813–823. doi:10.2337/diacare.27.3.813
Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102(51):18425–18430. doi:10.1073/pnas.0508621102
Pociot F, McDermott MF (2002) Genetics of type 1 diabetes mellitus. Genes Immun 3(5):235–249. doi:10.1038/sj.gene.6363875
Podolin PL, Pressey A, DeLarato NH, Fischer PA, Peterson LB, Wicker LS (1993) I-E+ nonobese diabetic mice develop insulitis and diabetes. J Exp Med 178(3):793–803. doi:10.1084/jem.178.3.793
Pop-Busui R, Pietropaolo M (2011) Metabolic syndrome and inflammation. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 69–92
Prummel MF, Strieder T, Wiersinga WM (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150(5):605–618
Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ (1995) Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 36(6):874–879. doi:10.1136/gut.36.6.874
Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD (1997) The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15(3):293–297
Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos C (2007) Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56(4):1174–1176. doi:10.2337/db06-1555
Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M, Maiuri L (2004) Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 10(9):920–926. doi:10.1038/nm1092
Quax RA, Peeters RP, Feelders RA (2011) Selective glucocorticoid receptor modulators: future of glucocorticoid immunosuppressive therapy? Endocrinology 152(8):2927–2929. doi:10.1210/en.2011-1258
Rabinowe SL, Larsen PR, Antman EM, George KL, Friedman PL, Jackson RA, Eisenbarth GS (1986) Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med 81(1):53–57
Rapoport B, Aliesky HA, Banuelos B, Chen CR, McLachlan SM (2015) A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor. J Immunol 194(9):4154–4161. doi:10.4049/jimmunol.1500126
Rasooly L, Burek CL, Rose NR (1996) Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 81(3):287–292. doi:10.1006/clin.1996.0191
Redmon JB, Nuttall FQ (1999) Autoimmune hypoglycemia. Endocrinol Metab Clin North Am 28(3):603–618. doi:10.1016/S0889-8529(05)70090-6
Retana-Marquez S, Bonilla-Jaime H, Vazquez-Palacios G, Dominguez-Salazar E, Martinez-Garcia R, Velazquez-Moctezuma J (2003) Body weight gain and diurnal differences of corticosterone changes in response to acute and chronic stress in rats. Psychoneuroendocrinology 28(2):207–227
Reulecke M, Dumas M, Meier C (1988) Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology 38(4):614–616
Rodriguez M, Lorenzo V (2009) Parathyroid hormone, a uremic toxin. Semin Dial 22(4):363–368. doi:10.1111/j.1525-139X.2009.00581.x
Roesch LF, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, Li N, Mai V, Wasserfall CH, Schatz D, Atkinson MA, Neu J, Triplett EW (2009) Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 3(5):536–548. doi:10.1038/ismej.2009.5
Rose NR, Witebsky E (1956) Studies on organ specificity: V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76(6):417–427
Rosenthal FD, Davies MK, Burden AC (1978) Malignant disease presenting as Addison's disease. Br Med J 1(6127):1591–1592
Rosol TJ, Gröne A (2015) Endocrine glands. In: Maxie MG (ed) Jubb, Kennedy & Palmer's pathology of domestic animals, vol 3, 6th edn. Saunders, Philadelphia, PA, pp 269–357
Rosol TJ, Yarrington JT, Latendresse J, Capen CC (2001) Adrenal gland: structure, function, and mechanisms of toxicity. Toxicol Pathol 29(1):41–48
Rotondi M, Falorni A, De Bellis A, Laureti S, Ferruzzi P, Romagnani P, Buonamano A, Lazzeri E, Crescioli C, Mannelli M, Santeusanio F, Bellastella A, Serio M (2005) Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. J Clin Endocrinol Metab 90(4):2357–2363. doi:10.1210/jc.2004-1062
Rottembourg D, Deal C, Lambert M, Mallone R, Carel JC, Lacroix A, Caillat-Zucman S, le Deist F (2010) 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J Autoimmun 35(4):309–315. doi:10.1016/j.jaut.2010.07.001
Roycroft M, Fichna M, McDonald D, Owen K, Zurawek M, Gryczynska M, Januszkiewicz-Lewandowska D, Fichna P, Cordell H, Donaldson P, Nowak J, Pearce S (2009) The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxf) 70(3):358–362. doi:10.1111/j.1365-2265.2008.03380.x
Ruíz-Giardín JM, Cremades C, Romero J, Marazuela M (2002) Insulin autoimmune syndrome in a patient with viral hepatitis C. Clin Endocrinol (Oxf) 57(3):411–412. doi:10.1046/j.1365-2265.2002.01604.x
Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E (2009) Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum 60(6):1743–1752. doi:10.1002/art.24500
Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T (2006) Foxp3 + CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212(1):8–27. doi:10.1111/j.0105-2896.2006.00427.x
Schoneveld JL, Fritsch-Stork RD, Bijlsma JW (2011) Nongenomic glucocorticoid signaling: new targets for immunosuppressive therapy? Arthritis Rheum 63(12):3665–3667. doi:10.1002/art.30635
Selye H (1955) Stress and disease. Science 122(3171):625–631
Shevach EM (2001) Certified professionals: Cd4(+)Cd25(+) suppressor T cells. J Exp Med 193(11):f41–f46
Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SCL (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocrinol Metabol 91(3):1056–1061. doi:10.1210/jc.2005-1634
Simmonds MJ, Howson JM, Heward JM, Carr-Smith J, Franklyn JA, Todd JA, Gough SC (2007) A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet 16(18):2149–2153. doi:10.1093/hmg/ddm165
Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB, Lovas K, Egeland T, Undlien DE (2008) Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 93(9):3310–3317. doi:10.1210/jc.2008-0821
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JHM, Howson JMM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359(26):2767–2777. doi:10.1056/NEJMoa0807917
Spangelo BL (1997) Cytokines and endocrine function. In: Conn PM, Melmed S (eds) Endocrinology: basic and clinical principles. Humana, Totowa, NJ, pp 115–128
Spangelo BL, Judd AM, Call GB, Zumwalt J, Gorospe WC (1995) Role of the cytokines in the hypothalamic-pituitary-adrenal and gonadal axes. Neuroimmunomodulation 2(5):299–312
Starkey K, Janezic A, Jones G, Jordan N, Baker G, Ludgate M (2003) Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol 30(3):369–380. doi:10.1677/jme.0.0300369
Stefan M, Wei C, Lombardi A, Li CW, Concepcion ES, Inabnet WB, Owen R, Zhang W, Tomer Y (2014) Genetic–epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity. Proc Natl Acad Sci 111(34):12562–12567. doi:10.1073/pnas.1408821111
Stelzer IA, Arck PC (2016) Immunity and the endocrine system. In: Ratcliffe MJH (ed) Encyclopedia of immunobiology, vol 5. Elsevier, Amsterdam, pp 73–85
Szymczak I, Pawliczak R (2016) The active metabolite of vitamin D3 as a potential immunomodulator. Scand J Immunol 83(2):83–91. doi:10.1111/sji.12403
Tai N, Wong FS, Wen L (2016) The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes. J Autoimmun. doi:10.1016/j.jaut.2016.03.006
Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res Paediatr 55(6):288–292
Tanaka S, Tatsumi K, Kimura M, Takano T, Murakami Y, Takao T, Hashimoto K, Kato Y, Amino N (2002) Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. Eur J Endocrinol 147(6):767–775. doi:10.1530/eje.0.1470767
Tashiro T, Sano T, Xu B, Wakatsuki S, Kagawa N, Nishioka H, Yamada S, Kovacs K (2002) Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr Pathol 13(3):183–195. doi:10.1385/ep:13:3:183
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2002) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143
Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF (2003) Common and unique susceptibility loci in graves and hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73(4):736–747
Tomer Y, Blackard JT, Akeno N (2007) Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 36(4):1051–1066. doi:10.1016/j.ecl.2007.07.001, x-xi
Toribio RE, Kohn CW, Capen CC, Rosol TJ (2003) Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function. J Mol Endocrinol 31(3):609–620
Torino F, Barnabei A, Paragliola RM, Marchetti P, Salvatori R, Corsello SM (2013) Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol 169(6):R153–R164. doi:10.1530/EJE-13-0434
Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y (2008) Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 8(2):112–115. doi:10.1016/j.autrev.2008.07.013
Tucker MJ (1984) A survey of the pathology of marmosets (Callithrix jacchus) under experiment. Lab Anim 18(4):351–358
Tzou SC, Lupi I, Landek M, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149(7):3461–3469. doi:10.1210/en.2007-1692
Uchigata Y, Hirata Y (2011) Insulin autoimmune syndrome (Hirata disease). In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 343–367
Uchigata Y, Hirata Y, Iwamoto Y (2009) Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract 83(1):e19–e20. doi:10.1016/j.diabres.2008.10.015
Uchigata Y, Tokunaga K, Nepom G, Bannai M, Kuwata S, Dozio N, Benson EA, Ronningen KS, Spinas GA, Tadokoro K, Hirata Y, Juji T, Omori Y (1995) Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata's disease) and monoclonal insulin autoimmune syndrome. Diabetes 44(10):1227–1232
Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15(3):289–292
van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91(1):79–118. doi:10.1152/physrev.00003.2010
van Bergen J, Mulder CJ, Mearin ML, Koning F (2015) Local communication among mucosal immune cells in patients with celiac disease. Gastroenterology 148(6):1187–1194. doi:10.1053/j.gastro.2015.01.030
van der Werf N, Kroese FGM, Rozing J, Hillebrands J-L (2007) Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23(3):169–183. doi:10.1002/dmrr.695
Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, Nika K, Tautz L, Tasken K, Cucca F, Mustelin T, Bottini N (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37(12):1317–1319. doi:10.1038/ng1673
Verdu EF, Galipeau HJ, Jabri B (2015) Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol 12(9):497–506. doi:10.1038/nrgastro.2015.90
Vidal S, Rotondo F, Horvath E, Kovacs K, Scheithauer BW (2002) Immunocytochemical localization of mast cells in lymphocytic hypophysitis. Am J Clin Pathol 117(3):478–483. doi:10.1309/a7n5-08dq-rhet-n57h
Vivier E, Nunès JA, Vély F (2004) Natural killer cell signaling pathways. Science 306(5701):1517–1519. doi:10.1126/science.1103478
Wang S, Baker JR (2011) Immunopathogenesis of thyroiditis. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 443–455
Weber J (2007) Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist 12(7):864–872. doi:10.1634/theoncologist.12-7-864
Wei WZ, Jacob JB, Zielinski JF, Flynn JC, Shim KD, Alsharabi G, Giraldo AA, Kong YC (2005) Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice. Cancer Res 65(18):8471–8478. doi:10.1158/0008-5472.CAN-05-0934
Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Investig 116(1):115–124. doi:10.1172/JCI24335
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216):1109–1113. doi:10.1038/nature07336
Wilcox NS, Rui J, Hebrok M, Herold KC (2016) Life and death of beta cells in type 1 diabetes: a comprehensive review. J Autoimmun. doi:10.1016/j.jaut.2016.02.001
Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155(2):173–181. doi:10.1111/j.1365-2249.2008.03860.x
Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2010) Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 53(9):2020–2028. doi:10.1007/s00125-010-1817-6
Wu G, Flynn NE (1993) The activation of the arginine-citrulline cycle in macrophages from the spontaneously diabetic BB rat. Biochem J 294(Pt 1):113–118
Wu S, Cai T, Chen F, He X, Cui Z (2015) Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population. Int J Clin Exp Med 8(9):16948–16954
Xiao X, Chang C (2014) Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun 48–49:66–72. doi:10.1016/j.jaut.2014.01.005
Yamamoto I, Bringhurst FR, Potts JT Jr, Segre GV (1988) Properties of parathyroid hormone receptors on circulating bovine lymphocytes. J Bone Miner Res 3(3):289–295. doi:10.1002/jbmr.5650030307
Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ, Eisenbarth GS (1999) DRB104 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison’s disease. J Clin Endocrinol Metabol 84(1):328–335. doi:10.1210/jcem.84.1.5414
Yu S, Dunn R, Kehry MR, Braley-Mullen H (2008) B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2 h4 mice. J Immunol 180(11):7706–7713. doi:10.4049/jimmunol.180.11.7706
Zhang L, Eisenbarth GS (2011) Immunopathogenesis of the NOD mouse. In: Eisenbarth GS (ed) Immunoendocrinology: scientific and clinical aspects. Humana, New York, NY, pp 199–213
Zhang Y, Lee AS, Shameli A, Geng X, Finegood D, Santamaria P, Dutz JP (2010) TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol 184(10):5645–5653. doi:10.4049/jimmunol.0901814
Zhe D, Fang H, Yuxiu S (2008) Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats. Acta Histochem Cytochem 41(4):89–95. doi:10.1267/ahc.08013
Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10(1):43–55. doi:10.1038/nrg2489
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rosol, T.J., Walling, B.E. (2017). Immunopathology of the Endocrine System. In: Parker, G. (eds) Immunopathology in Toxicology and Drug Development. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-47385-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-47385-7_13
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-47384-0
Online ISBN: 978-3-319-47385-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)